Menopausal symptoms pose a significant challenge for breast cancer survivors, arising either directly from cancer treatments like adjuvant endocrine therapy or ovarian function suppression in hormone-receptor-positive (HR +) breast cancer, or after discontinuation of hormone replacement therapy. The gene discussed is NR4A1; the disease is breast carcinoma.